Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Levetiracetam × Lymphoid × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4 Sarcoma 1 Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Rituximab 701 Cyclophosphamide 639 Vincristine 349 Doxorubicin 303 Etoposide 302 Cytarabine 269 Filgrastim 250 Prednisone 247 Methotrexate 239 fludarabine phosphate 231 Dexamethasone 207 fludarabine 182 Peripheral Blood Stem Cell Transplantation 164 Radiotherapy 160 Granulocyte Colony-Stimulating Factor 145 Lenalidomide 144 Bendamustine Hydrochloride 142 Melphalan 126 Bortezomib 126 ibrutinib 111 Busulfan 110 Mycophenolic Acid 107 Whole-Body Irradiation 106 Tacrolimus 96 Cyclosporine 86 Gemcitabine 82 Ifosfamide 80 Alemtuzumab 80 Calcium Dobesilate 78 Leucovorin 76

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02348216 2024-06-04

ZUMA-1

Gilead Sciences

Phase 1/2 Completed

307 enrolled 41 charts

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡